Insufficient scRNA-seq data for expression of MAP1LC3B2 at single-cell level.
Insufficient scRNA-seq data for expression of MAP1LC3B2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 96% | 94.36 | 2527 / 2642 | 100% | 5.26 | 704 / 705 |
skin | 97% | 48.77 | 1759 / 1809 | 96% | 3.20 | 454 / 472 |
kidney | 94% | 33.20 | 84 / 89 | 97% | 3.33 | 875 / 901 |
breast | 98% | 49.02 | 449 / 459 | 93% | 2.37 | 1044 / 1118 |
adrenal gland | 88% | 21.41 | 228 / 258 | 96% | 2.69 | 220 / 230 |
lung | 88% | 21.94 | 510 / 578 | 94% | 2.55 | 1089 / 1155 |
uterus | 93% | 66.61 | 158 / 170 | 87% | 1.75 | 400 / 459 |
esophagus | 89% | 22.29 | 1279 / 1445 | 89% | 2.76 | 162 / 183 |
thymus | 76% | 16.99 | 498 / 653 | 98% | 2.69 | 592 / 605 |
ovary | 99% | 129.74 | 179 / 180 | 73% | 1.61 | 314 / 430 |
prostate | 90% | 31.35 | 221 / 245 | 81% | 1.36 | 407 / 502 |
intestine | 84% | 21.58 | 816 / 966 | 77% | 1.67 | 405 / 527 |
bladder | 67% | 12.52 | 14 / 21 | 75% | 1.52 | 376 / 504 |
stomach | 55% | 11.16 | 198 / 359 | 82% | 1.94 | 234 / 286 |
pancreas | 28% | 4.46 | 93 / 328 | 91% | 1.96 | 162 / 178 |
lymph node | 0% | 0 | 0 / 0 | 100% | 2.76 | 29 / 29 |
ureter | 0% | 0 | 0 / 0 | 100% | 1.67 | 1 / 1 |
muscle | 98% | 34.96 | 786 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 98% | 84.88 | 909 / 929 | 0% | 0 | 0 / 0 |
adipose | 98% | 43.57 | 1178 / 1204 | 0% | 0 | 0 / 0 |
spleen | 95% | 29.51 | 229 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 93% | 2.41 | 42 / 45 |
blood vessel | 81% | 19.21 | 1085 / 1335 | 0% | 0 | 0 / 0 |
heart | 81% | 21.66 | 694 / 861 | 0% | 0 | 0 / 0 |
liver | 32% | 6.71 | 73 / 226 | 46% | 0.76 | 187 / 406 |
eye | 0% | 0 | 0 / 0 | 68% | 1.44 | 54 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0000422 | Biological process | autophagy of mitochondrion |
GO_0097352 | Biological process | autophagosome maturation |
GO_0006995 | Biological process | cellular response to nitrogen starvation |
GO_0000045 | Biological process | autophagosome assembly |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0000421 | Cellular component | autophagosome membrane |
GO_0005874 | Cellular component | microtubule |
GO_0031410 | Cellular component | cytoplasmic vesicle |
GO_0012505 | Cellular component | endomembrane system |
GO_0008017 | Molecular function | microtubule binding |
GO_0008429 | Molecular function | phosphatidylethanolamine binding |
GO_0031625 | Molecular function | ubiquitin protein ligase binding |
Gene name | MAP1LC3B2 |
Protein name | Microtubule-associated proteins 1A/1B light chain 3 beta 2 (Microtubule-associated proteins 1A/1B light chain 3B-like) |
Synonyms | |
Description | FUNCTION: Ubiquitin-like modifier involved in formation of autophagosomal vacuoles (autophagosomes). Plays a role in mitophagy which contributes to regulate mitochondrial quantity and quality by eliminating the mitochondria to a basal level to fulfill cellular energy requirements and preventing excess ROS production. In response to cellular stress and upon mitochondria fission, binds C-18 ceramides and anchors autophagolysosomes to outer mitochondrial membranes to eliminate damaged mitochondria. While LC3s are involved in elongation of the phagophore membrane, the GABARAP/GATE-16 subfamily is essential for a later stage in autophagosome maturation. . |
Accessions | A6NCE7 ENST00000556529.4 |